Researchers have predicted that cases of glaucoma, a common eye condition that can lead to blindness if not treated, are expected to increase around the world in the coming years.

The FDA cleared an investigational new drug application for NTX-1024 ophthalmic solution in vernal keratoconjunctivitis, ...

“I could hardly see,” she recalled. “I was losing my vision and nobody was able to tell me why,” she told ABC. The source of the problem was not in her eyes at all. It was a tattoo on her back, inked ...

Emerging research suggests early signs of Alzheimer’s disease may appear in the peripheral retina. Experts say Optical ...

After treatment, the mice’s memories were essentially shunted back into a younger state. The researchers found that reprogrammed engrams displayed molecular behavior of more youthful cells. Using a ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

The early part of the year brings not only cold weather, but also awareness for the “sneak thief of sight,” glaucoma. The devastation that the disease can bring is particularly challenging for African ...

"That $99 saved my life," Ronnie Paul said of the test that showed he was at immediate risk of a heart attack ...

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...